JP2019508382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508382A5 JP2019508382A5 JP2018536429A JP2018536429A JP2019508382A5 JP 2019508382 A5 JP2019508382 A5 JP 2019508382A5 JP 2018536429 A JP2018536429 A JP 2018536429A JP 2018536429 A JP2018536429 A JP 2018536429A JP 2019508382 A5 JP2019508382 A5 JP 2019508382A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- use according
- inhibitor
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662278671P | 2016-01-14 | 2016-01-14 | |
| US62/278,671 | 2016-01-14 | ||
| PCT/US2017/013818 WO2017124110A1 (en) | 2016-01-14 | 2017-01-17 | Inhibition of allergic reaction using an il-33 inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019508382A JP2019508382A (ja) | 2019-03-28 |
| JP2019508382A5 true JP2019508382A5 (https=) | 2020-02-27 |
Family
ID=59311527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018536429A Abandoned JP2019508382A (ja) | 2016-01-14 | 2017-01-17 | Ｉｌ−３３阻害剤を使用したアレルギー反応の阻害 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20190016795A1 (https=) |
| EP (1) | EP3402521A4 (https=) |
| JP (1) | JP2019508382A (https=) |
| KR (1) | KR20180101533A (https=) |
| CN (1) | CN109475622A (https=) |
| AU (1) | AU2017208099A1 (https=) |
| BR (1) | BR112018014247A2 (https=) |
| CA (1) | CA3011547A1 (https=) |
| EA (1) | EA201891628A1 (https=) |
| MX (1) | MX2018008732A (https=) |
| SG (2) | SG11201805900YA (https=) |
| WO (1) | WO2017124110A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201605580RA (en) | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
| JP2019516362A (ja) | 2016-04-27 | 2019-06-20 | ファイザー・インク | 抗ｉｌ−３３抗体、その組成物、方法および使用 |
| JOP20190093A1 (ar) | 2016-10-28 | 2019-04-25 | Lilly Co Eli | أجسام مضادة لـ il-33 واستخداماتها |
| GB201712952D0 (en) * | 2017-08-11 | 2017-09-27 | Univ Edinburgh | Immunomodulatory agent |
| EP3694877A1 (en) * | 2017-10-09 | 2020-08-19 | AnaptysBio, Inc. | Anti-il-33 therapy for atopic dermatitis |
| WO2019183639A1 (en) * | 2018-03-23 | 2019-09-26 | Anaptysbio, Inc. | Inhibition of allergic reaction to peanut allergen using an il-33 inhibitor |
| TW202021983A (zh) * | 2018-09-21 | 2020-06-16 | 美商安納普提斯生物公司 | 用於嗜伊紅性氣喘之抗il-33療法 |
| US20230099101A1 (en) * | 2020-03-06 | 2023-03-30 | The Regents Of The University Of Michigan | Serine protease inhibitors for suppressing or preventing anaphylactic reaction |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7560530B1 (en) * | 2006-07-20 | 2009-07-14 | Schering Corporation | IL-33 receptor |
| IE20080331A1 (en) * | 2007-04-26 | 2009-07-08 | Trinity College Dublin | Products for altering cytokine activity and methods therefor |
| US9090694B2 (en) * | 2012-04-30 | 2015-07-28 | Janssen Biotech, Inc. | ST2L antibody antagonists |
| AR091069A1 (es) * | 2012-05-18 | 2014-12-30 | Amgen Inc | Proteinas de union a antigeno dirigidas contra el receptor st2 |
| JO3532B1 (ar) * | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| WO2014152195A1 (en) * | 2013-03-15 | 2014-09-25 | Regeneron Pharmaceuticals, Inc. | Il-33 antagonists and uses thereof |
| KR101567758B1 (ko) * | 2013-10-17 | 2015-11-11 | 인하대학교 산학협력단 | 항-Siglec-8 항체 또는 항-Siglec-F 항체, 및 항-IL-33 항체를 포함하는 알러지 질환의 예방 또는 치료용 조성물 |
| BR112016013347B1 (pt) * | 2013-12-26 | 2023-12-12 | Mitsubishi Tanabe Pharma Corporation | Anticorpo monoclonal humano neutralizante anti-il-33, composição farmacêutica, inibidor da expressão de citocinas, molécula de ácido nucleico, vetor, célula bacteriana transgênica, método de produção e uso dos mesmos |
| SG11201605580RA (en) * | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
-
2017
- 2017-01-17 SG SG11201805900YA patent/SG11201805900YA/en unknown
- 2017-01-17 KR KR1020187023332A patent/KR20180101533A/ko not_active Withdrawn
- 2017-01-17 EA EA201891628A patent/EA201891628A1/ru unknown
- 2017-01-17 EP EP17739165.3A patent/EP3402521A4/en not_active Withdrawn
- 2017-01-17 MX MX2018008732A patent/MX2018008732A/es unknown
- 2017-01-17 US US16/070,200 patent/US20190016795A1/en not_active Abandoned
- 2017-01-17 SG SG10202006699XA patent/SG10202006699XA/en unknown
- 2017-01-17 JP JP2018536429A patent/JP2019508382A/ja not_active Abandoned
- 2017-01-17 BR BR112018014247A patent/BR112018014247A2/pt not_active IP Right Cessation
- 2017-01-17 CN CN201780014394.8A patent/CN109475622A/zh active Pending
- 2017-01-17 CA CA3011547A patent/CA3011547A1/en not_active Abandoned
- 2017-01-17 WO PCT/US2017/013818 patent/WO2017124110A1/en not_active Ceased
- 2017-01-17 AU AU2017208099A patent/AU2017208099A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019508382A5 (https=) | ||
| EA200970879A1 (ru) | Связывающие белки, включающие антитела, производные антител и фрагменты антител, которые специфически связываются с cd154, и их применения | |
| CN102492038B (zh) | 抗人Tim-3的中和性单克隆抗体L3D及其用途 | |
| JP2021502984A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2016020389A5 (https=) | ||
| WO2016207304A8 (en) | Monoclonal anti-il-1racp antibodies | |
| JP2020504076A5 (https=) | ||
| EA201190132A1 (ru) | Гуманизированные антитела, связывающиеся с cd19, и их применение | |
| JP2018512379A5 (https=) | ||
| JP2011509245A5 (https=) | ||
| RU2018102606A (ru) | Молекулы, связывающиеся с psl pseudomonas, и пути их применения | |
| JP2015503909A5 (https=) | ||
| JP2013518903A5 (https=) | ||
| RU2014101707A (ru) | АНТИ-Axl АНТИТЕЛА И ИХ ПРИМЕНЕНИЕ | |
| JP2014518883A5 (https=) | ||
| JP2016183153A5 (https=) | ||
| JP2012012402A5 (https=) | ||
| HRP20150934T1 (hr) | Djelovanje na abcb5 u terapiji raka | |
| JP2017523984A5 (https=) | ||
| JP2016523235A5 (https=) | ||
| JP2015508063A5 (https=) | ||
| JP2016538297A5 (https=) | ||
| JP2018507254A5 (https=) | ||
| JP2018512417A5 (https=) |